Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
نویسندگان
چکیده
منابع مشابه
Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.
Metabolite profiling is being increasing employed in the study of prostate cancer as a means of identifying predictive, diagnostic, and prognostic biomarkers. This review provides a summary and critique of the current literature. Thirty-three human case-control studies of prostate cancer exploring disease prediction, diagnosis, progression, or treatment response were identified. All but one dem...
متن کاملBiomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
Despite advances in the management of non-small cell lung cancer, it remains to be the leading cause of cancer-related deaths worldwide primarily because of diagnosis at a late stage with an overall 5-year survival rate of 17%. A reduction in mortality was achieved by low-dose computed tomography screening of high-risk patients. However, the benefit was later challenged by the high false positi...
متن کاملEmerging biomarkers for the diagnosis and prognosis of prostate cancer.
BACKGROUND Early detection of prostate cancer (CaP), the most prevalent cancer and the second-leading cause of death in men, has proved difficult, and current detection methods are inadequate. Prostate-specific antigen (PSA) testing is a significant advance for early diagnosis of patients with CaP. CONTENT PSA is produced almost exclusively in the prostate, and abnormalities of this organ are...
متن کاملNovel Biomarkers in Determining Prostate Cancer Diagnosis and Prognosis
Corresponding Author: Zuzana Varchulova Novakova Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovakia E-mail: [email protected] Abstract: The clinical behavior and molecular pathology of prostate cancer is highly variable. Current “traditional” prognostic markers cannot reliably distinguish the potentially lif...
متن کاملBiomarkers and prostate cancer progression.
A n international team of researchers believe they may have found, if not the smoking gun, at least a few DNA “bullets” that determine whether prostate cancer will become aggressive. A new biomarker study, which appeared in the Aug. 16, 2011, online edition of Cancer Epidemiology, Biomarkers, and Prevention, identified five inherited genetic variants associated with aggressive prostate cancer. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Epidemiology Biomarkers & Prevention
سال: 2016
ISSN: 1055-9965,1538-7755
DOI: 10.1158/1055-9965.epi-15-1223